|Articles|February 11, 2009
Laser + IVTA for PDR and DME
Combined Laser and Intravitreal Triamcinolone for Proliferative Diabetic Retinopathy and Macular Edema: One-year Results of a Randomized Clinical Trial
Advertisement
Combined Laser and Intravitreal Triamcinolone for Proliferative Diabetic Retinopathy and Macular Edema: One-year Results of a Randomized Clinical Trial
, from the February 2009 issue of the
American Journal of Ophthalmology
.
Please click
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















